Table 2.

Comorbidity and concomitant medication in patients with successful and failed treatment results

	Successful (n=58), n (%)	Failed (n=173), n (%)	P
BPH	33 (56.9)	98 (60.9)	0.597
DM	17 (29.3)	40 (24.8)	0.506
COPD	3 (5.2)	7 (4.3)	0.727
CAD	6 (10.3)	17 (10.6)	0.964
CVA	6 (10.3)	11 (6.8)	0.398
CKD	8 (13.8)	20 (12.4)	0.789
PD	1 (1.7)	1 (0.6)	0.460
Dementia	2 (3.4)	4 (2.5)	0.657
Antimuscarinics	0	1 (0.6)	1.000
Alpha-blocker/5ARI	25 (43.1)	73 (45.3)	0.769

BPH: Benign prostatic hyperplasia, DM: Diabetes mellitus, COPD: Chronic obstructive pulmonary disease, CAD: Cardiac arterial disease, CVA: Cerebrovascular disease, CKD: Chronic kidney disease, PD: Parkinson’s disease, 5ARI: 5-alpha-reductase inhibitor